KalVista Pharmaceuticals (KALV) Change in Acquisitions & Divestments (2019 - 2025)

KalVista Pharmaceuticals (KALV) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $41.7 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 9.02% year-over-year to $41.7 million; the trailing twelve-month figure through Jul 2025 stood at $149.0 million (up 52.35% YoY), and the FY2025 full-year result was $122.5 million, up 16.74% from the prior year.
• Change in Acquisitions & Divestments climbed to $41.7 million in Q3 2025, from $20.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $65.0 million in Q2 2022 to a low of $7.9 million in Q2 2021.
• A 5-year average of $34.0 million and a median of $36.2 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 718.34% in 2022 and slumped 77.41% in 2024, its largest moves.
• Tracing KALV's Change in Acquisitions & Divestments over 5 years: stood at $50.7 million in 2021, then slumped by 59.95% to $20.3 million in 2022, then soared by 60.33% to $32.5 million in 2023, then jumped by 50.24% to $48.9 million in 2024, then slipped by 14.73% to $41.7 million in 2025.
• Business Quant data shows KALV's Change in Acquisitions & Divestments at $41.7 million in Q3 2025, $20.2 million in Q2 2025, and $48.9 million in Q4 2024.